Genzyme up on takeout speculation

Genzyme Corp. (NASDAQ:GENZ) gained $8.35 (15%) to $62.52 on Friday after media reports surfaced that sanofi-aventis Group (Euronext:SAN; NYSE:SNY) had approached the biotech with an informal acquisiti...